References
- Brown BB, Werner HW. The pharmacologic properties of doxylamine succinate, a new antihistaminic agent. J Lab Clin Med 1948; 33:325–331.
- Köppel C, Tenczer J, Ibe K. Poisoning with over-the-counter doxylamine preparations: an evaluation of 109 cases. Hum Toxicol 1987; 6:355–359.
- Meadow SR, Leeson GA. Poisoning with delayed-release tablets. Treatment of Debendox poisoning with purgation and dialysis. Arch Dis Child 1974; 49:310–312.
- Bayley M, Walsh FM, Valaske MJ. Fatal overdose from Bendectin. Clin Pediatr (Phila) 1975; 14:507–509, 514.
- Turk EE, Ewald A. A fatal complication of doxylamine in a 1-year-old girl. Int J Legal Med 2012; 126:447–449.
- Jo YI, Song JO, Park JH, Koh SY, Lee SM, Seo TH, Lee JH. Risk factors for rhabdomyolysis following doxylamine overdose. Hum Exp Toxicol 2007; 26:617–621.
- Kim HJ, Oh SH, Youn CS, Wee JH, Kim JH, Jeong WJ, et al. The associative factors of delayed-onset rhabdomyolysis in patients with doxylamine overdose. Am J Emerg Med 2011; 29:903–907.
- Scharman EJ, Erdman AR, Wax PM, Chyka PA, Caravati EM, Nelson LS, et al. Diphenhydramine and dimenhydrinate poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 2006; 44:205–223.
- Paul IM, Yoder KE, Crowell KR, Shaffer ML, McMillan HS, Carlson LC, et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114:e85–90.
- Balan G, Thompson GA, Gibb R, Li L, Hull D, Seeck M, et al. Doxylamine pharmacokinetics following single dose oral administration in children ages 2–17 years. J Clin Pharmacol 2013; 53:1177–1185.